FDA Brief

Warning letters Devices

FDA warning letter to

Sea-Long Medical Systems, LLC

High riskIssued Apr 4, 2023Posted May 16, 2023Division of Medical Device and Radiological Health Operations West

FDA warns Sea-Long Medical Systems over Treatment Hood quality failures and unapproved uses.

What happened

FDA inspected Sea-Long Medical Systems in Waxahachie, TX, from 08/22/2022 through 09/08/2022 and found failures in complaint handling, process validation, CAPA, finished-device acceptance, and device records. FDA also reviewed the firm's website and labeling and found promoted uses such as NIV, ARDS, PSV/PEEP, and COVID-19 without a new 510(k), and labels without a unique device identifier (UDI).

What FDA found

  1. Complaint records for hood holes, leaks, and rips did not document complaint details, investigation dates/results, CAPA/root-cause forms, why no investigation was done, who decided, a complaint log, product IDs, or serial numbers.

    21 CFR 820.198(a)
  2. The firm did not validate the welding process or the cleaning process for reusable Treatment Hoods.

    21 CFR 820.75(a)
  3. The firm had no CAPA procedure; its master list pointed to an old procedure whose electronic file was corrupt and could not be opened.

    21 CFR 820.100(a)
  4. The firm had no written finished-device acceptance procedure and did not keep completed Inspection Specification Sheets.

    21 CFR 820.80(d)
  5. The firm did not maintain device master records and did not establish device history records; the last documented device history record was from 2018 even though manufacturing continued.

    21 CFR 820.181; 21 CFR 820.184
  6. The website, YouTube, and Directions for Use promoted NIV, ARDS, PSV/PEEP, and COVID-19 uses without a new 510(k).

    section 502(o) of the Act, 21 U.S.C. ยง 352(o); section 510(k)

What FDA wants

FDA asks the firm to correct the cited Quality System and labeling violations and to provide documentation or evidence. The provided letter text does not state a response deadline.

Who should pay attention

  • hospitals and clinicians using treatment hoods
  • suppliers of latex and non-latex neck seals
  • device firms with complaint and CAPA systems

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Conroe Welding Supply, Inc.

    FDA warns Conroe Welding Supply over medical oxygen manufacturing failures, including untested batches and a container with 99% (b)(4).

    High risk
  2. Peter Schiff Enterprises

    FDA warns Peter Schiff Enterprises over unapproved cardiac devices and serious quality system failures.

    High risk
  3. Chirp Innovations, LLC

    FDA warned Chirp Innovations over quality-system gaps, missing adverse-event reporting procedures, and unapproved marketing of its Halo muscle stimulator for menstrual pain.

    High risk
  4. Rohto Pharmaceutical Co., Ltd.

    FDA cites Rohto Vietnam eye-drop plant for falsified sterility records, poor aseptic practices, and unapproved Cooling Eye Drops.

    High risk